{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:28:22Z","timestamp":1793330902336,"version":"4.5.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s40257-024-00915-7","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T12:43:48Z","timestamp":1736599428000},"page":"237-250","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9577-5092","authenticated-orcid":false,"given":"Kayla D.","family":"Mashoudy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Farhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Elman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"915_CR1","unstructured":"Litchman G, Nair PA, Syed HA, Le JK. Pityriasis Rosea. 2024 Mar 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 28846360."},{"issue":"1","key":"915_CR2","first-page":"38","volume":"97","author":"JM Villalon-Gomez","year":"2018","unstructured":"Villalon-Gomez JM. Pityriasis rosea: diagnosis and treatment. Am Fam Physician. 2018;97(1):38\u201344.","journal-title":"Am Fam Physician"},{"issue":"2","key":"915_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaad.2008.07.045","volume":"61","author":"F Drago","year":"2009","unstructured":"Drago F, Broccolo F, Rebora A. Pityriasis rosea: an update with a critical appraisal of its possible herpesviral etiology. J Am Acad Dermatol. 2009;61(2):303\u201318.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"915_CR4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000445375","volume":"232","author":"F Drago","year":"2016","unstructured":"Drago F, Ciccarese G, Rebora A, Broccolo F, Parodi A. Pityriasis rosea: a comprehensive classification. Dermatology. 2016;232(4):431\u20137.","journal-title":"Dermatology"},{"issue":"5","key":"915_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/0378-6323.16779","volume":"71","author":"A Chuh","year":"2005","unstructured":"Chuh A, Lee A, Zawar V, Sciallis G, Kempf W. Pityriasis rosea\u2014an update. Indian J Dermatol Venereol Leprol. 2005;71(5):311\u20135.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"915_CR6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1007412330146","volume":"14","author":"M Harman","year":"1998","unstructured":"Harman M, Aytekin S, Akdeniz S, Inaloz HS. An epidemiological study of pityriasis rosea in the Eastern Anatolia. Eur J Epidemiol. 1998;14(5):495\u20137.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"915_CR7","first-page":"704","volume":"40","author":"H Yahya","year":"2023","unstructured":"Yahya H. Pityriasis rosea in Kaduna, North-West Nigeria: a 20-year experience. West Afr J Med. 2023;40(7):704\u201310.","journal-title":"West Afr J Med"},{"issue":"1","key":"915_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4314\/nqjhm.v20i1.57989","volume":"20","author":"O Ayanlowo","year":"2010","unstructured":"Ayanlowo O, Akinkugbe A, Olumide Y. The pityriasis rosea calendar: a 7 year review of seasonal variation, age and sex distribution. Nig Q J Hosp Med. 2010;20(1):29\u201331.","journal-title":"Nig Q J Hosp Med"},{"issue":"1","key":"915_CR9","volume":"14","author":"J Gandhi","year":"2022","unstructured":"Gandhi J, Agrawal S, Gupta S, Verma K, Mohite A. Pattern of papulosquamous disorders in children: a clinico-epidemiological study. Cureus. 2022;14(1): e21194.","journal-title":"Cureus"},{"key":"915_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdin.2022.04.006","volume":"8","author":"TP Joshi","year":"2022","unstructured":"Joshi TP, Calderara GA, Lipoff JB. Prevalence of pityriasis rosea in the United States: a cross-sectional study using the All of Us database. JAAD Int. 2022;8:45\u20136.","journal-title":"JAAD Int"},{"issue":"3","key":"915_CR11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1017\/S0950268804002304","volume":"132","author":"A Chuh","year":"2004","unstructured":"Chuh A, Chan H, Zawar V. Pityriasis rosea\u2014evidence for and against an infectious aetiology. Epidemiol Infect. 2004;132(3):381\u201390.","journal-title":"Epidemiol Infect"},{"issue":"7","key":"915_CR12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-3169","volume":"99","author":"M Yuksel","year":"2019","unstructured":"Yuksel M. Pityriasis rosea recurrence is much higher than previously known: a prospective study. Acta Derm Venereol. 2019;99(7):664\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"915_CR13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-4362.1980.tb03738.x","volume":"19","author":"WK Jacyk","year":"1980","unstructured":"Jacyk WK. Pityriasis rosea in Nigerians. Int J Dermatol. 1980;19(7):397\u20139.","journal-title":"Int J Dermatol"},{"issue":"4","key":"915_CR14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/0019-5154.185699","volume":"61","author":"K Mahajan","year":"2016","unstructured":"Mahajan K, Relhan V, Relhan AK, Garg VK. Pityriasis rosea: an update on etiopathogenesis and management of difficult aspects. Indian J Dermatol. 2016;61(4):375\u201384.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"915_CR15","first-page":"CD005068","volume":"18","author":"AA Chuh","year":"2007","unstructured":"Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, Garner SE, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007;18(2):CD005068.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"915_CR16","first-page":"201","volume":"17","author":"AKC Leung","year":"2021","unstructured":"Leung AKC, Lam JM, Leong KF, Hon KL. Pityriasis rosea: an updated review. Curr Pediatr Rev. 2021;17(3):201\u201311.","journal-title":"Curr Pediatr Rev"},{"key":"915_CR17","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-3179","author":"I Engelmann","year":"2018","unstructured":"Engelmann I, Ogiez J, Ogiez L, Alidjinou EK, Lazrek M, Dewilde A, et al. Relapsing pityriasis rosea with HHV-7 reactivation in an 11-year-old girl. Pediatrics. 2018. https:\/\/doi.org\/10.1542\/peds.2017-3179.","journal-title":"Pediatrics"},{"issue":"1","key":"915_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000070931","volume":"207","author":"F Drago","year":"2003","unstructured":"Drago F, Rebora A. Viral reactivation and skin eruptions. Dermatology. 2003;207(1):1\u20132.","journal-title":"Dermatology"},{"issue":"5","key":"915_CR19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clindermatol.2010.03.005","volume":"28","author":"A Rebora","year":"2010","unstructured":"Rebora A, Drago F, Broccolo F. Pityriasis rosea and herpesviruses: facts and controversies. Clin Dermatol. 2010;28(5):497\u2013501.","journal-title":"Clin Dermatol"},{"issue":"4","key":"915_CR20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcv.2014.09.020","volume":"61","author":"F Broccolo","year":"2014","unstructured":"Broccolo F, Ciccarese G, Oggioni M, Rebora A, Parodi A, Drago F. The saliva quantitative PCR assay is inadequate to detect and monitor human herpesvirus-7 and -6 reactivation in patients with pityriasis rosea. J Clin Virol. 2014;61(4):615\u20136.","journal-title":"J Clin Virol"},{"issue":"3","key":"915_CR21","first-page":"173","volume":"30","author":"E Caselli","year":"2007","unstructured":"Caselli E, Di Luca D. Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7. New Microbiol. 2007;30(3):173\u201387.","journal-title":"New Microbiol"},{"issue":"2 Pt 1","key":"915_CR22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0190-9622(00)90132-4","volume":"42","author":"PK Sharma","year":"2000","unstructured":"Sharma PK, Yadav TP, Gautam RK, Taneja N, Satyanarayana L. Erythromycin in pityriasis rosea: a double-blind, placebo-controlled clinical trial. J Am Acad Dermatol. 2000;42(2 Pt 1):241\u20134.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"915_CR23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/0019-5154.44787","volume":"53","author":"M Parija","year":"2008","unstructured":"Parija M, Thappa DM. Study of role of streptococcal throat infection in pityriasis rosea. Indian J Dermatol. 2008;53(4):171\u20133.","journal-title":"Indian J Dermatol"},{"issue":"1","key":"915_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/jdv.12701","volume":"29","author":"F Guarneri","year":"2015","unstructured":"Guarneri F, Cannavo SP, Minciullo PL, Gangemi S. Pityriasis rosea of Gibert: immunological aspects. J Eur Acad Dermatol Venereol. 2015;29(1):21\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"915_CR25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archderm.1985.01660060075025","volume":"121","author":"S Aiba","year":"1985","unstructured":"Aiba S, Tagami H. Immunohistologic studies in pityriasis rosea. Evidence for cellular immune reaction in the lesional epidermis. Arch Dermatol. 1985;121(6):761\u20135.","journal-title":"Arch Dermatol"},{"issue":"7","key":"915_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF00429978","volume":"280","author":"H Sugiura","year":"1988","unstructured":"Sugiura H, Miyauchi H, Uehara M. Evolutionary changes of immunohistological characteristics of secondary lesions in pityriasis rosea. Arch Dermatol Res. 1988;280(7):405\u201310.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"915_CR27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2230.2009.03469.x","volume":"35","author":"CY Neoh","year":"2010","unstructured":"Neoh CY, Tan AW, Mohamed K, Sun YJ, Tan SH. Characterization of the inflammatory cell infiltrate in herald patches and fully developed eruptions of pityriasis rosea. Clin Exp Dermatol. 2010;35(3):300\u20134.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"915_CR28","first-page":"209","volume":"68","author":"BS Baker","year":"1988","unstructured":"Baker BS, Lambert S, Powles AV, Valdimarsson H, Fry L. Epidermal DR+T6- dendritic cells in inflammatory skin diseases. Acta Derm Venereol. 1988;68(3):209\u201317.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"915_CR29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2340\/0001555565132137","volume":"65","author":"JD Bos","year":"1985","unstructured":"Bos JD, Huisman PM, Krieg SR, Faber WR. Pityriasis rosea (Gibert): abnormal distribution pattern of antigen presenting cells in situ. Acta Derm Venereol. 1985;65(2):132\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"915_CR30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/1523-1747.ep12524811","volume":"87","author":"JD Bos","year":"1986","unstructured":"Bos JD, van Garderen ID, Krieg SR, Poulter LW. Different in situ distribution patterns of dendritic cells having Langerhans (T6+) and interdigitating (RFD1+) cell immunophenotype in psoriasis, atopic dermatitis, and other inflammatory dermatoses. J Investig Dermatol. 1986;87(3):358\u201361.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"915_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00424268","volume":"281","author":"JD Bos","year":"1989","unstructured":"Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML. Predominance of \u201cmemory\u201d T cells (CD4+, CDw29+) over \u201cnaive\u201d T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res. 1989;281(1):24\u201330.","journal-title":"Arch Dermatol Res"},{"key":"915_CR32","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/438963","volume":"2015","author":"F Drago","year":"2015","unstructured":"Drago F, Ciccarese G, Broccolo F, Ghio M, Contini P, Thanasi H, et al. The role of cytokines, chemokines, and growth factors in the pathogenesis of pityriasis rosea. Mediat Inflamm. 2015;2015: 438963.","journal-title":"Mediat Inflamm"},{"issue":"10","key":"915_CR33","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1468-3083.2006.01721.x","volume":"20","author":"S Gangemi","year":"2006","unstructured":"Gangemi S, Cannavo SP, Guarneri F, Merendino RA, Sturniolo GC, Minciullo PL, et al. The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea. J Eur Acad Dermatol Venereol. 2006;20(10):1366\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"915_CR34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1468-3083.2008.03067.x","volume":"23","author":"S Gangemi","year":"2009","unstructured":"Gangemi S, Minciullo PL, Guarneri F, Cristani M, Arcoraci T, Spatari G, et al. Increased serum levels of interleukin-22 in patients affected by pityriasis rosea. J Eur Acad Dermatol Venereol. 2009;23(7):858\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"915_CR35","unstructured":"Gay JT, Huq ME, Saleh HM, Gross GP. Herald Patch. 2024 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 30020673."},{"issue":"3","key":"915_CR36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdv.12942","volume":"30","author":"F Drago","year":"2016","unstructured":"Drago F, Ciccarese G, Javor S, Parodi A. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. J Eur Acad Dermatol Venereol. 2016;30(3):544\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"915_CR37","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15225","volume":"35","author":"F Martora","year":"2022","unstructured":"Martora F, Fabbrocini G, Marasca C. Pityriasis rosea after Moderna mRNA-1273 vaccine: a case series. Dermatol Ther. 2022;35(2): e15225.","journal-title":"Dermatol Ther"},{"issue":"5","key":"915_CR38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clindermatol.2022.01.002","volume":"40","author":"F Drago","year":"2022","unstructured":"Drago F, Broccolo F, Ciccarese G. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination. Clin Dermatol. 2022;40(5):586\u201390.","journal-title":"Clin Dermatol"},{"issue":"1","key":"915_CR39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000362640","volume":"6","author":"D Papakostas","year":"2014","unstructured":"Papakostas D, Stavropoulos PG, Papafragkaki D, Grigoraki E, Avgerinou G, Antoniou C. An atypical case of pityriasis rosea gigantea after influenza vaccination. Case Rep Dermatol. 2014;6(1):119\u201323.","journal-title":"Case Rep Dermatol"},{"key":"915_CR40","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdin.2022.05.015","volume":"9","author":"F Drago","year":"2022","unstructured":"Drago F, Ciccarese G. Pityriasis rosea during COVID-19 and its pathogenesis. JAAD Int. 2022;9:159\u201360.","journal-title":"JAAD Int."},{"key":"915_CR41","doi-asserted-by":"publisher","DOI":"10.5070\/D3232033971","author":"N Gupta","year":"2017","unstructured":"Gupta N, Levitt JO. Unique clinical presentations of pityriasis rosea: aphthous ulcers, vesicles and inverse distribution of lesions. Dermatol Online J. 2017. https:\/\/doi.org\/10.5070\/D3232033971.","journal-title":"Dermatol Online J"},{"issue":"9","key":"915_CR42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-4632.2005.02635.x","volume":"44","author":"LM Gonzalez","year":"2005","unstructured":"Gonzalez LM, Allen R, Janniger CK, Schwartz RA. Pityriasis rosea: an important papulosquamous disorder. Int J Dermatol. 2005;44(9):757\u201364.","journal-title":"Int J Dermatol"},{"issue":"1","key":"915_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D380D8301D","volume":"12","author":"L Atzori","year":"2006","unstructured":"Atzori L, Pinna AL, Ferreli C, Aste N. Pityriasis rosea-like adverse reaction: review of the literature and experience of an Italian drug-surveillance center. Dermatol Online J. 2006;12(1):1.","journal-title":"Dermatol Online J"},{"issue":"8","key":"915_CR44","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/archderm.1980.01640320052013","volume":"116","author":"JK Wilkin","year":"1980","unstructured":"Wilkin JK, Hammond JJ, Kirkendall WM. The captopril-induced eruption. A possible mechanism: cutaneous kinin potentiation. Arch Dermatol. 1980;116(8):902\u20135.","journal-title":"Arch Dermatol"},{"issue":"3","key":"915_CR45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archderm.1982.01650150048022","volume":"118","author":"JK Wilkin","year":"1982","unstructured":"Wilkin JK, Kirkendall WM. Pityriasis rosea-like rash from captopril. Arch Dermatol. 1982;118(3):186\u20137.","journal-title":"Arch Dermatol"},{"issue":"10","key":"915_CR46","first-page":"457","volume":"125","author":"I Ghersetich","year":"1990","unstructured":"Ghersetich I, Rindi L, Teofoli P, Tsampau D, Palleschi GM, Lotti T. Pityriasis rosea-like skin eruptions caused by captopril. G Ital Dermatol Venereol. 1990;125(10):457\u20139.","journal-title":"G Ital Dermatol Venereol"},{"issue":"1","key":"915_CR47","first-page":"98","volume":"31","author":"LA Reinhardt","year":"1983","unstructured":"Reinhardt LA, Wilkin JK, Kirkendall WM. Lichenoid eruption produced by captopril. Cutis. 1983;31(1):98\u20139.","journal-title":"Cutis"},{"issue":"3","key":"915_CR48","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0960327115580220","volume":"35","author":"AI Gulec","year":"2016","unstructured":"Gulec AI, Albayrak H, Kayapinar O, Albayrak S. Pityriasis rosea-like adverse reaction to atenolol. Hum Exp Toxicol. 2016;35(3):229\u201331.","journal-title":"Hum Exp Toxicol"},{"issue":"3","key":"915_CR49","first-page":"166","volume":"77","author":"NM Hanjani","year":"2006","unstructured":"Hanjani NM, Rencic A, Whitmore SE. Pityriasis rosea-like eruption due to bismuth. Cutis. 2006;77(3):166\u20138.","journal-title":"Cutis"},{"issue":"7","key":"915_CR50","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007611-194907000-00005","volume":"42","author":"WL Dobes","year":"1949","unstructured":"Dobes WL, Alden HS. Pityriasis rosea-like drug eruptions due to bismuth. South Med J. 1949;42(7):572\u20139.","journal-title":"South Med J"},{"issue":"4","key":"915_CR51","volume":"10","author":"S Saad","year":"2022","unstructured":"Saad S, Gammoudi R, Abdessayed N, Denguezli M. Domperidone-induced pityriasis rosea-like drug eruption. Clin Case Rep. 2022;10(4): e05674.","journal-title":"Clin Case Rep."},{"issue":"3","key":"915_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/rheumatology\/22.3.187","volume":"22","author":"CF Corke","year":"1983","unstructured":"Corke CF, Meyrick TR, Huskisson EC, Kirby JD. Pityriasis rosea-like rashes complicating drug therapy for rheumatoid arthritis. Br J Rheumatol. 1983;22(3):187\u20138.","journal-title":"Br J Rheumatol"},{"issue":"32","key":"915_CR53","first-page":"1555","volume":"25","author":"JM Bonnetblanc","year":"1996","unstructured":"Bonnetblanc JM. Cutaneous reactions to gold salts. Presse Med. 1996;25(32):1555\u20138.","journal-title":"Presse Med"},{"issue":"7","key":"915_CR54","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/ard.51.7.881","volume":"51","author":"SM Wilkinson","year":"1992","unstructured":"Wilkinson SM, Smith AG, Davis MJ, Mattey D, Dawes PT. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold. Ann Rheum Dis. 1992;51(7):881\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"915_CR55","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000063900","volume":"205","author":"K Konstantopoulos","year":"2002","unstructured":"Konstantopoulos K, Papadogianni A, Dimopoulou M, Kourelis C, Meletis J. Pityriasis rosea associated with imatinib (STI571, Gleevec). Dermatology. 2002;205(2):172\u20133.","journal-title":"Dermatology"},{"key":"915_CR56","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/cup.14692","volume":"51","author":"JS Durgin","year":"2024","unstructured":"Durgin JS, Whittington CP, Harrell J, Mervak JE, Smith EH. Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: a case report and review of the literature. J Cutan Pathol. 2024;51:860\u20135.","journal-title":"J Cutan Pathol"},{"issue":"3","key":"915_CR57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/ijd.IJD_51_19","volume":"67","author":"IG Isik","year":"2022","unstructured":"Isik IG, Cakmak SK, Ozhamam E. A rare case of pityriasis rosea-like lichenoid drug eruption due to imatinib treatment. Indian J Dermatol. 2022;67(3):315.","journal-title":"Indian J Dermatol"},{"issue":"Suppl 3","key":"915_CR58","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.5021\/ad.2011.23.S3.S360","volume":"23","author":"AY Cho","year":"2011","unstructured":"Cho AY, Kim DH, Im M, Lee Y, Seo YJ, Lee JH. Pityriasis rosea-like drug eruption induced by imatinib mesylate (Gleevec). Ann Dermatol. 2011;23(Suppl 3):S360\u20133.","journal-title":"Ann Dermatol"},{"key":"915_CR59","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.ad.2020.01.010","volume":"112","author":"S Valenzuela-Ubina","year":"2021","unstructured":"Valenzuela-Ubina S, Villegas-Romero I, Jimenez-Gallo D, Linares-Barrios M. Pityriasis rosea-like eruption induced by imatinib in a patient with a gastrointestinal stromal tumor. Actas Dermosifiliogr (Engl Ed). 2021;112:853\u20136.","journal-title":"Actas Dermosifiliogr (Engl Ed)."},{"issue":"3","key":"915_CR60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.4103\/0019-5154.131433","volume":"59","author":"P Verma","year":"2014","unstructured":"Verma P, Singal A, Sharma S. Imatinib mesylate-induced cutaneous rash masquerading as pityriasis rosea of gilbert. Indian J Dermatol. 2014;59(3):311\u20132.","journal-title":"Indian J Dermatol"},{"issue":"5 Suppl 1","key":"915_CR61","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1016\/j.jaad.2004.10.888","volume":"53","author":"V Brazzelli","year":"2005","unstructured":"Brazzelli V, Prestinari F, Roveda E, Barbagallo T, Bellani E, Vassallo C, et al. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases. J Am Acad Dermatol. 2005;53(5 Suppl 1):S240\u20133.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"915_CR62","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5152\/balkanmedj.2012.109","volume":"30","author":"R Guner","year":"2013","unstructured":"Guner R, Keske S, Hasanoglu I, Tasyaran M. Pityriasis rosea associated with pegylated interferon alfa and ribavirin treatment in a patient with chronic hepatitis C. Balkan Med J. 2013;30(2):253\u20134.","journal-title":"Balkan Med J"},{"issue":"1","key":"915_CR63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000356176","volume":"228","author":"F Drago","year":"2014","unstructured":"Drago F, Javor S, Bruzzone L, Drago F, Parodi A, Picciotto A. Pityriasis rosea in a hepatitis B-positive patient treated with pegylated interferon alpha2a: report of a case and review of the literature. Dermatology. 2014;228(1):10\u20133.","journal-title":"Dermatology"},{"issue":"4","key":"915_CR64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1346-8138.1999.tb03461.x","volume":"26","author":"C Durusoy","year":"1999","unstructured":"Durusoy C, Alpsoy E, Yilmaz E. Pityriasis rosea in a patient with Behcet\u2019s disease treated with interferon alpha 2A. J Dermatol. 1999;26(4):225\u20138.","journal-title":"J Dermatol"},{"issue":"1","key":"915_CR65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/15569527.2017.1312430","volume":"37","author":"G Gurel","year":"2018","unstructured":"Gurel G, Sahin S, Colgecen E. Pityriasis rosea-like eruption induced by isotretinoin. Cutan Ocul Toxicol. 2018;37(1):100\u20132.","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"915_CR66","first-page":"297","volume":"33","author":"RJ Helfman","year":"1984","unstructured":"Helfman RJ, Brickman M, Fahey J. Isotretinoin dermatitis simulating acute pityriasis rosea. Cutis. 1984;33(3):297\u2013300.","journal-title":"Cutis"},{"issue":"4","key":"915_CR67","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1365-2133.1996.tb03863.x","volume":"135","author":"C Buckley","year":"1996","unstructured":"Buckley C. Pityriasis rosea-like eruption in a patient receiving omeprazole. Br J Dermatol. 1996;135(4):660\u20131.","journal-title":"Br J Dermatol"},{"issue":"10","key":"915_CR68","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.1977.01640100135034","volume":"113","author":"JC Maize","year":"1977","unstructured":"Maize JC, Tomecki KJ. Pityriasis rosea-like drug eruption secondary to metronidazole. Arch Dermatol. 1977;113(10):1457\u20138.","journal-title":"Arch Dermatol"},{"issue":"4","key":"915_CR69","first-page":"198","volume":"124","author":"G Yosipovitch","year":"1993","unstructured":"Yosipovitch G, Kuperman O, Livni E, Avinoach I, Halevy S. Pityriasis rosea-like eruption after anti-inflammatory and antipyretic medication. Harefuah. 1993;124(4):198\u2013200 (47).","journal-title":"Harefuah"},{"issue":"1","key":"915_CR70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4103\/ijpd.ijpd_1_24","volume":"25","author":"DRC Behera","year":"2024","unstructured":"Behera DRC, Bajoria S, Jain K, Sukhija R. Ibuprofen-induced pityriasis rosea and fixed-drug eruption. Indian J Paediatric Dermatol. 2024;25(1):46\u20138.","journal-title":"Indian J Paediatric Dermatol."},{"issue":"5","key":"915_CR71","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/bcp.13560","volume":"84","author":"MM Alame","year":"2018","unstructured":"Alame MM, Chamsy DJ, Zaraket H. Pityriasis rosea-like eruption associated with ondansetron use in pregnancy. Br J Clin Pharmacol. 2018;84(5):1077\u201380.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"915_CR72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1365-2133.1998.02140.x","volume":"138","author":"AK Gupta","year":"1998","unstructured":"Gupta AK, Lynde CW, Lauzon GJ, Mehlmauer MA, Braddock SW, Miller CA, et al. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol. 1998;138(3):529\u201332.","journal-title":"Br J Dermatol"},{"issue":"7","key":"915_CR73","first-page":"1048","volume":"19","author":"P Nenoff","year":"2021","unstructured":"Nenoff P, Klonowski E, Dunzendorfer H, Gerisch M, Pohl M, Uhrlass S, et al. Kerion Celsi due to Trichophyton soudanense and pityriasis rosea following treatment by terbinafine. J Dtsch Dermatol Ges. 2021;19(7):1048\u201351.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"6","key":"915_CR74","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4103\/0253-7613.169574","volume":"47","author":"A George","year":"2015","unstructured":"George A, Bhatia A, Kanish B, Williams A. Terbinafine induced pityriasis rosea-like eruption. Indian J Pharmacol. 2015;47(6):680\u20131.","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"915_CR75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/LGT.0b013e31825d7c5f","volume":"17","author":"HK Bangash","year":"2013","unstructured":"Bangash HK, Finch T, Petronic-Rosic V, Sethi A, Abramsohn E, Lindau ST. Pityriasis rosea-like drug eruption due to nortriptyline in a patient with vulvodynia. J Low Genit Tract Dis. 2013;17(2):226\u20139.","journal-title":"J Low Genit Tract Dis"},{"issue":"9","key":"915_CR76","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1468-3083.2007.02197.x","volume":"21","author":"SN Rajpara","year":"2007","unstructured":"Rajpara SN, Ormerod AD, Gallaway L. Adalimumab-induced pityriasis rosea. J Eur Acad Dermatol Venereol. 2007;21(9):1294\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"915_CR77","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/1346-8138.12445","volume":"41","author":"T Ohtsuka","year":"2014","unstructured":"Ohtsuka T. Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris. J Dermatol. 2014;41(4):354\u20135.","journal-title":"J Dermatol"},{"issue":"5","key":"915_CR78","first-page":"383","volume":"13","author":"C Guarneri","year":"2009","unstructured":"Guarneri C, Polimeni G, Nunnari G. Pityriasis rosea during etanercept therapy. Eur Rev Med Pharmacol Sci. 2009;13(5):383\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"915_CR79","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jfma.2021.12.028","volume":"121","author":"CS Wang","year":"2022","unstructured":"Wang CS, Chen HH, Liu SH. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: a case report and literature review. J Formos Med Assoc. 2022;121(5):1003\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"915_CR80","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1468-3083.2003.00519_4.x","volume":"17","author":"AA Chuh","year":"2003","unstructured":"Chuh AA. Diagnostic criteria for pityriasis rosea: a prospective case control study for assessment of validity. J Eur Acad Dermatol Venereol. 2003;17(1):101\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"915_CR81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s13555-016-0141-6","volume":"6","author":"E Errichetti","year":"2016","unstructured":"Errichetti E, Stinco G. Dermoscopy in general dermatology: a practical overview. Dermatol Ther (Heidelb). 2016;6(4):471\u2013507.","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"5","key":"915_CR82","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaad.2017.06.033","volume":"77","author":"G Ciccarese","year":"2017","unstructured":"Ciccarese G, Broccolo F, Rebora A, Parodi A, Drago F. Oropharyngeal lesions in pityriasis rosea. J Am Acad Dermatol. 2017;77(5):833\u20137 (e4).","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"915_CR83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/archderm.1976.01630270072021","volume":"112","author":"RL Garcia","year":"1976","unstructured":"Garcia RL. Letter: vesicular pityriasis rosea. Arch Dermatol. 1976;112(3):410.","journal-title":"Arch Dermatol"},{"issue":"6","key":"915_CR84","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0190-9622(08)80661-5","volume":"28","author":"JC Pierson","year":"1993","unstructured":"Pierson JC, Dijkstra JW, Elston DM. Purpuric pityriasis rosea. J Am Acad Dermatol. 1993;28(6):1021.","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"915_CR85","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1468-3083.2004.01105.x","volume":"19","author":"A Chuh","year":"2005","unstructured":"Chuh A, Zawar V, Lee A. Atypical presentations of pityriasis rosea: case presentations. J Eur Acad Dermatol Venereol. 2005;19(1):120\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"915_CR86","first-page":"51","volume":"70","author":"RM Bernardin","year":"2002","unstructured":"Bernardin RM, Ritter SE, Murchland MR. Papular pityriasis rosea. Cutis. 2002;70(1):51\u20135 (quiz 48).","journal-title":"Cutis"},{"issue":"3","key":"915_CR87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/0019-5154.110855","volume":"58","author":"V Relhan","year":"2013","unstructured":"Relhan V, Sinha S, Garg VK, Khurana N. Pityriasis rosea with erythema multiforme - like lesions: an observational analysis. Indian J Dermatol. 2013;58(3):242.","journal-title":"Indian J Dermatol"},{"issue":"2","key":"915_CR88","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3315\/jdcr.2012.1095","volume":"6","author":"V Zawar","year":"2012","unstructured":"Zawar V, Chuh A. Follicular pityriasis rosea. A case report and a new classification of clinical variants of the disease. J Dermatol Case Rep. 2012;6(2):36\u20139.","journal-title":"J Dermatol Case Rep"},{"issue":"5","key":"915_CR89","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.1997.03890410111017","volume":"133","author":"MD Gibney","year":"1997","unstructured":"Gibney MD, Leonardi CL. Acute papulosquamous eruption of the extremities demonstrating an isomorphic response. Inverse pityriasis rosea (PR). Arch Dermatol. 1997;133(5):651 (4).","journal-title":"Arch Dermatol"},{"issue":"3","key":"915_CR90","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1111\/j.1440-0960.2011.00808.x","volume":"53","author":"M Polat","year":"2012","unstructured":"Polat M, Yildirim Y, Makara A. Palmar herald patch in pityriasis rosea. Australas J Dermatol. 2012;53(3):e64\u20135.","journal-title":"Australas J Dermatol"},{"issue":"1","key":"915_CR91","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/2229-5178.73253","volume":"1","author":"V Zawar","year":"2010","unstructured":"Zawar V. Acral pityriasis rosea in an infant with palmoplantar lesions: a novel manifestation. Indian Dermatol Online J. 2010;1(1):21\u20133.","journal-title":"Indian Dermatol Online J"},{"issue":"1","key":"915_CR92","first-page":"42","volume":"69","author":"BK Brar","year":"2003","unstructured":"Brar BK, Pall A, Gupta RR. Pityriasis rosea unilateralis. Indian J Dermatol Venereol Leprol. 2003;69(1):42\u20133.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"915_CR93","first-page":"54","volume":"4","author":"V Zawar","year":"2010","unstructured":"Zawar V. Unilateral pityriasis rosea in a child. J Dermatol Case Rep. 2010;4(4):54\u20136.","journal-title":"J Dermatol Case Rep."},{"issue":"5","key":"915_CR94","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaad.2009.01.004","volume":"61","author":"CC Ang","year":"2009","unstructured":"Ang CC, Tay YK. Blaschkoid pityriasis rosea. J Am Acad Dermatol. 2009;61(5):906\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"915_CR95","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-2230.2000.00723.x","volume":"25","author":"I Ahmed","year":"2000","unstructured":"Ahmed I, Charles-Holmes R. Localized pityriasis rosea. Clin Exp Dermatol. 2000;25(8):624\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"915_CR96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0974-7753.77524","volume":"2","author":"V Zawar","year":"2010","unstructured":"Zawar V. Pityriasis amiantacea-like eruptions in scalp: a novel manifestation of pityriasis rosea in a child. Int J Trichol. 2010;2(2):113\u20135.","journal-title":"Int J Trichol"},{"issue":"5","key":"915_CR97","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpedi.161.5.503","volume":"161","author":"A Amer","year":"2007","unstructured":"Amer A, Fischer H, Li X. The natural history of pityriasis rosea in black American children: how correct is the \u201cclassic\u201d description? Arch Pediatr Adolesc Med. 2007;161(5):503\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"915_CR98","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0019-5154.131457","volume":"59","author":"S Sankararaman","year":"2014","unstructured":"Sankararaman S, Velayuthan S. Multiple recurrences in pityriasis rosea\u2014a case report with review of the literature. Indian J Dermatol. 2014;59(3):316.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"915_CR99","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000363568","volume":"229","author":"F Drago","year":"2014","unstructured":"Drago F, Ciccarese G, Rebora A, Parodi A. Relapsing pityriasis rosea. Dermatology. 2014;229(4):316\u20138.","journal-title":"Dermatology"},{"issue":"5 Suppl 1","key":"915_CR100","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2007.05.030","volume":"58","author":"F Drago","year":"2008","unstructured":"Drago F, Broccolo F, Zaccaria E, Malnati M, Cocuzza C, Lusso P, et al. Pregnancy outcome in patients with pityriasis rosea. J Am Acad Dermatol. 2008;58(5 Suppl 1):S78-83.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"915_CR101","first-page":"953","volume":"20","author":"L Wenger-Oehn","year":"2022","unstructured":"Wenger-Oehn L, Graier T, Ambros-Rudolph C, Mullegger R, Bittighofer C, Wolf P, et al. Pityriasis rosea in pregnancy: a case series and literature review. J Dtsch Dermatol Ges. 2022;20(7):953\u20139.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"915_CR102","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1479-828X.2005.00399.x","volume":"45","author":"AA Chuh","year":"2005","unstructured":"Chuh AA, Lee A, Chan PK. Pityriasis rosea in pregnancy\u2014specific diagnostic implications and management considerations. Aust N Z J Obstet Gynaecol. 2005;45(3):252\u20133.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"4","key":"915_CR103","first-page":"312","volume":"24","author":"A Monastirli","year":"2016","unstructured":"Monastirli A, Pasmatzi E, Badavanis G, Tsambaos D. Gestational pityriasis rosea: suggestions for approaching affected pregnant women. Acta Dermatovenerol Croat. 2016;24(4):312\u20133.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"915_CR104","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/ijd.ijd_1071_23","volume":"69","author":"AA Shende","year":"2024","unstructured":"Shende AA, Chikhalkar SB. A cross-sectional study of epidemiological and clinical aspects of pityriasis rosea along with dermoscopic analysis and histopathology correlation. Indian J Dermatol. 2024;69(2):145\u201351.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"915_CR105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5114\/pdia.2014.40641","volume":"31","author":"GD Ozyurek","year":"2014","unstructured":"Ozyurek GD, Alan S, Cenesizoglu E. Evaluation of clinico-epidemiological and histopathological features of pityriasis rosea. Postepy Dermatol Alergol. 2014;31(4):216\u201321.","journal-title":"Postepy Dermatol Alergol."},{"issue":"6","key":"915_CR106","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.0022-202X.2005.23719.x","volume":"124","author":"F Broccolo","year":"2005","unstructured":"Broccolo F, Drago F, Careddu AM, Foglieni C, Turbino L, Cocuzza CE, et al. Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. J Investig Dermatol. 2005;124(6):1234\u201340.","journal-title":"J Investig Dermatol"},{"issue":"4","key":"915_CR107","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000245991","volume":"195","author":"F Drago","year":"1997","unstructured":"Drago F, Ranieri E, Malaguti F, Battifoglio ML, Losi E, Rebora A. Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin. Dermatology. 1997;195(4):374\u20138.","journal-title":"Dermatology"},{"issue":"8","key":"915_CR108","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/diagnostics14080843","volume":"14","author":"M Aydin Kurc","year":"2024","unstructured":"Aydin Kurc M, Erfan G, Kaya AD, Gulen D, Oznur M, Yanik ME. Association between pityriasis rosea (PR) and HHV-6\/HHV-7 infection: importance of sample selection and diagnostic techniques. Diagnostics (Basel). 2024;14(8):843.","journal-title":"Diagnostics (Basel)."},{"issue":"4","key":"915_CR109","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/ajd.12244","volume":"56","author":"GR Moloney","year":"2015","unstructured":"Moloney GR, Goh MS, Mitchell C, McCormack CJ. Localised pityriasis rosea-like eruption during radiotherapy. Report of 2 cases. Australas J Dermatol. 2015;56(4):303\u20136.","journal-title":"Australas J Dermatol"},{"issue":"2","key":"915_CR110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15569527.2016.1225217","volume":"36","author":"F Kilinc","year":"2017","unstructured":"Kilinc F, Akbas A, Sener S, Aktas A. Atypical pityriasis rosea: clinical evaluation of 27 patients. Cutan Ocul Toxicol. 2017;36(2):157\u201362.","journal-title":"Cutan Ocul Toxicol"},{"issue":"1","key":"915_CR111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000368352","volume":"230","author":"F Drago","year":"2015","unstructured":"Drago F, Broccolo F, Ciccarese G, Rebora A, Parodi A. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. Dermatology. 2015;230(1):23\u20136.","journal-title":"Dermatology"},{"issue":"1","key":"915_CR112","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.11622\/smedj.2013190","volume":"55","author":"SY Chuah","year":"2014","unstructured":"Chuah SY, Chia HY, Tan HH. Recurrent and persistent pityriasis rosea: an atypical case presentation. Singap Med J. 2014;55(1):e4-6.","journal-title":"Singap Med J"},{"issue":"5","key":"915_CR113","volume":"15","author":"N Wong","year":"2023","unstructured":"Wong N, Cascardo CA, Mansour M, Qian V, Potts GA. A review of pityriasis rosea in relation to SARS-CoV-2\/COVID-19 infection and vaccination. Cureus. 2023;15(5): e38772.","journal-title":"Cureus."},{"issue":"4","key":"915_CR114","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MOP.0b013e32832db96e","volume":"21","author":"JC Browning","year":"2009","unstructured":"Browning JC. An update on pityriasis rosea and other similar childhood exanthems. Curr Opin Pediatr. 2009;21(4):481\u20135.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"915_CR115","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.804","volume":"11","author":"I Khan","year":"2023","unstructured":"Khan I, Elsanousi AA, Shareef AM, Tebha SS, Arif A, Gul S. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: a systematic review. Immun Inflamm Dis. 2023;11(4): e804.","journal-title":"Immun Inflamm Dis."},{"issue":"2","key":"915_CR116","first-page":"289","volume":"64","author":"S Hsu","year":"2001","unstructured":"Hsu S, Le EH, Khoshevis MR. Differential diagnosis of annular lesions. Am Fam Physician. 2001;64(2):289\u201396.","journal-title":"Am Fam Physician"},{"issue":"6","key":"915_CR117","doi-asserted-by":"crossref","first-page":"203","DOI":"10.12998\/wjcc.v5.i6.203","volume":"5","author":"F Urbina","year":"2017","unstructured":"Urbina F, Das A, Sudy E. Clinical variants of pityriasis rosea. World J Clin Cases. 2017;5(6):203\u201311.","journal-title":"World J Clin Cases."},{"key":"915_CR118","unstructured":"Givler DN, Saleh HM, Givler A. Pityriasis Alba. 2024 Jan 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan\u2013. PMID: 28613715."},{"issue":"2","key":"915_CR119","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5858\/arpa.2012-0101-RS","volume":"137","author":"O Radu","year":"2013","unstructured":"Radu O, Pantanowitz L. Kaposi sarcoma. Arch Pathol Lab Med. 2013;137(2):289\u201394.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"915_CR120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/ijd.14887","volume":"59","author":"G Ciccarese","year":"2020","unstructured":"Ciccarese G, Trave I, Herzum A, Parodi A, Drago F. Dermatological manifestations of Epstein\u2013Barr virus systemic infection: a case report and literature review. Int J Dermatol. 2020;59(10):1202\u20139.","journal-title":"Int J Dermatol"},{"key":"915_CR121","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jdcr.2023.11.031","volume":"45","author":"SA Saberi","year":"2024","unstructured":"Saberi SA, Kumar AM, Davis D, Nambudiri VE. Florid cutaneous morbilliform eruption in the setting of primary Epstein\u2013Barr virus infection. JAAD Case Rep. 2024;45:102\u20135.","journal-title":"JAAD Case Rep."},{"issue":"6","key":"915_CR122","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaad.2012.04.014","volume":"67","author":"F Drago","year":"2012","unstructured":"Drago F, Paolino S, Rebora A, Broccolo F, Drago F, Cardo P, et al. The challenge of diagnosing atypical exanthems: a clinico-laboratory study. J Am Acad Dermatol. 2012;67(6):1282\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"915_CR123","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/09546634.2018.1430302","volume":"29","author":"S Sonthalia","year":"2018","unstructured":"Sonthalia S, Kumar A, Zawar V, Priya A, Yadav P, Srivastava S, et al. Double-blind randomized placebo-controlled trial to evaluate the efficacy and safety of short-course low-dose oral prednisolone in pityriasis rosea. J Dermatolog Treat. 2018;29(6):617\u201322.","journal-title":"J Dermatolog Treat"},{"issue":"6","key":"915_CR124","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000250220","volume":"163","author":"JF Leonforte","year":"1981","unstructured":"Leonforte JF. Pityriasis rosea: exacerbation with corticosteroid treatment. Dermatologica. 1981;163(6):480\u20131.","journal-title":"Dermatologica"},{"issue":"4","key":"915_CR125","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14972","volume":"34","author":"G Paolino","year":"2021","unstructured":"Paolino G, Di Nicola MR, Cantisani C, Mercuri SR. Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection. Dermatol Ther. 2021;34(4): e14972.","journal-title":"Dermatol Ther"},{"issue":"6","key":"915_CR126","first-page":"775","volume":"136","author":"M Bigby","year":"2000","unstructured":"Bigby M. A remarkable result of a double-masked, placebo-controlled trial of erythromycin in the treatment of pityriasis rosea. Arch Dermatol. 2000;136(6):775\u20136.","journal-title":"Arch Dermatol"},{"issue":"1","key":"915_CR127","first-page":"35","volume":"7","author":"A Rasi","year":"2008","unstructured":"Rasi A, Tajziehchi L, Savabi-Nasab S. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol. 2008;7(1):35\u20138.","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"915_CR128","first-page":"625","volume":"7","author":"IA Bukhari","year":"2008","unstructured":"Bukhari IA. Oral erythromycin is ineffective in the treatment of pityriasis rosea. J Drugs Dermatol. 2008;7(7):625.","journal-title":"J Drugs Dermatol"},{"key":"915_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005068.pub3","author":"J Contreras-Ruiz","year":"2019","unstructured":"Contreras-Ruiz J, Peternel S, Jimenez Gutierrez C, Culav-Koscak I, Reveiz L, Silbermann-Reynoso ML. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2019. https:\/\/doi.org\/10.1002\/14651858.CD005068.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"915_CR130","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1590\/abd1806-4841.20187252","volume":"93","author":"M Rodriguez-Zuniga","year":"2018","unstructured":"Rodriguez-Zuniga M, Torres N, Garcia-Perdomo H. Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis. An Bras Dermatol. 2018;93(5):686\u201395.","journal-title":"An Bras Dermatol"},{"issue":"10","key":"915_CR131","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/jdv.13826","volume":"30","author":"A Chuh","year":"2016","unstructured":"Chuh A, Zawar V, Sciallis G, Kempf W. A position statement on the management of patients with pityriasis rosea. J Eur Acad Dermatol Venereol. 2016;30(10):1670\u201381.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"915_CR132","first-page":"YC01-4","volume":"8","author":"S Ganguly","year":"2014","unstructured":"Ganguly S. A randomized, double-blind, placebo-controlled study of efficacy of oral acyclovir in the treatment of pityriasis rosea. J Clin Diagn Res. 2014;8(5):YC01-4.","journal-title":"J Clin Diagn Res"},{"issue":"5","key":"915_CR133","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4103\/0378-6323.182791","volume":"82","author":"SA Singh","year":"2016","unstructured":"Singh SA, Tiwary NK. Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. Indian J Dermatol Venereol Leprol. 2016;82(5):505\u20139.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"915_CR134","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/09546634.2018.1508820","volume":"30","author":"HC Chang","year":"2019","unstructured":"Chang HC, Sung CW, Lin MH. The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis. J Dermatol Treat. 2019;30(3):288\u201393.","journal-title":"J Dermatol Treat"},{"issue":"5","key":"915_CR135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4103\/2229-5178.164480","volume":"6","author":"V Jairath","year":"2015","unstructured":"Jairath V, Mohan M, Jindal N, Gogna P, Syrty C, Monnappa PM, et al. Narrowband UVB phototherapy in pityriasis rosea. Indian Dermatol Online J. 2015;6(5):326\u20139.","journal-title":"Indian Dermatol Online J"},{"issue":"5","key":"915_CR136","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archderm.1983.01650290021010","volume":"119","author":"KA Arndt","year":"1983","unstructured":"Arndt KA, Paul BS, Stern RS, Parrish JA. Treatment of pityriasis rosea with UV radiation. Arch Dermatol. 1983;119(5):381\u20132.","journal-title":"Arch Dermatol"},{"issue":"6","key":"915_CR137","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0190-9622(95)90293-7","volume":"33","author":"V Leenutaphong","year":"1995","unstructured":"Leenutaphong V, Jiamton S. UVB phototherapy for pityriasis rosea: a bilateral comparison study. J Am Acad Dermatol. 1995;33(6):996\u20139.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"915_CR138","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1034\/j.1600-0781.2003.00029.x","volume":"19","author":"JP Castanedo-Cazares","year":"2003","unstructured":"Castanedo-Cazares JP, Lepe V, Moncada B. Should we still use phototherapy for pityriasis rosea? Photodermatol Photoimmunol Photomed. 2003;19(3):160\u20131.","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"915_CR139","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5021\/ad.2009.21.3.230","volume":"21","author":"SH Lim","year":"2009","unstructured":"Lim SH, Kim SM, Oh BH, Ko JH, Lee YW, Choe YB, et al. Low-dose ultraviolet al phototherapy for treating pityriasis rosea. Ann Dermatol. 2009;21(3):230\u20136.","journal-title":"Ann Dermatol"},{"issue":"4","key":"915_CR140","first-page":"265","volume":"30","author":"M Prtajin","year":"2022","unstructured":"Prtajin M, Ljubojevic HS. Pityriasis rosea after COVID-19 infection. Acta Dermatovenerol Croat. 2022;30(4):265\u20136.","journal-title":"Acta Dermatovenerol Croat"},{"issue":"1","key":"915_CR141","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2005.06.042","volume":"54","author":"F Drago","year":"2006","unstructured":"Drago F, Vecchio F, Rebora A. Use of high-dose acyclovir in pityriasis rosea. J Am Acad Dermatol. 2006;54(1):82\u20135.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-024-00915-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-024-00915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:28:36Z","timestamp":1740385716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-024-00915-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["915"],"URL":"https:\/\/doi.org\/10.1007\/s40257-024-00915-7","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"12 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"None to declare for Kayla Mashoudy, Sarah Kim, Leah Farhadi, or Scott Elman.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients signed informed consent regarding publishing their data and photographs.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent to participate\/publish"}},{"value":"The data analyzed in this review article are sourced from previously published studies and are accessible through the cited references. No new data was generated for this review.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Kayla Mashoudy: conceptualization, methodology, writing\u2014original and final draft preparation; Sarah Kim: material preparation, writing\u2014original draft preparation; Leah Farhadi: material preparation, writing\u2014original draft preparation; Scott Elman: supervision, writing, and manuscript review. All authors read and approved the final manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contribution"}}]}}